Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

Vitamin D status in men with psoriatic arthritis: a case-control study.

Petho Z, Kulcsar-Jakab E, Kalina E, Balogh A, Pusztai A, Gulyas K, Horvath A, Szekanecz Z, Bhattoa HP.

Osteoporos Int. 2015 Feb 19. [Epub ahead of print]

PMID:
25693749
2.

Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases.

Váradi C, Holló Z, Póliska S, Nagy L, Szekanecz Z, Váncsa A, Palatka K, Guttman A.

Electrophoresis. 2015 Jan 14. doi: 10.1002/elps.201400575. [Epub ahead of print]

PMID:
25639738
3.

Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.

Kurkó J, Vida A, Ocskó T, Tryniszewska B, Rauch TA, Glant TT, Szekanecz Z, Mikecz K.

PLoS One. 2014 Nov 4;9(11):e111815. doi: 10.1371/journal.pone.0111815. eCollection 2014.

4.

[Applicability of laser-based geological techniques in bone research: analysis of calcium oxide distribution in thin-cut animal bones].

Andrássy L, Maros G, Kovács IJ, Horváth Á, Gulyás K, Bertalan É, Besnyi A, Füri J, Fancsik T, Szekanecz Z, Bhattoa HP.

Orv Hetil. 2014 Nov 9;155(45):1783-93. doi: 10.1556/OH.2014.30010. Review. Hungarian.

PMID:
25362641
5.

Occurrence of pulmonary rheumatoid nodules following biological therapies.

Kovács A, Baksay B, Cserenyecz A, Molnár K, Takács M, Szekanecz Z.

Clin Rheumatol. 2014 Sep 30. [Epub ahead of print]

PMID:
25267563
6.

Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study.

Kurkó J, Vida A, Glant TT, Scanzello CR, Katz RS, Nair A, Mikecz K, Szekanecz Z.

BMC Musculoskelet Disord. 2014 Aug 19;15:281. doi: 10.1186/1471-2474-15-281.

7.

Rheumatoid arthritis and metabolic syndrome.

Kerekes G, Nurmohamed MT, González-Gay MA, Seres I, Paragh G, Kardos Z, Baráth Z, Tamási L, Soltész P, Szekanecz Z.

Nat Rev Rheumatol. 2014 Nov;10(11):691-6. doi: 10.1038/nrrheum.2014.121. Epub 2014 Aug 5.

PMID:
25090948
8.

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies.

Castañeda-Hernández G, Szekanecz Z, Mysler E, Azevedo VF, Guzman R, Gutierrez M, Rodríguez W, Karateev D.

Joint Bone Spine. 2014 Dec;81(6):471-7. doi: 10.1016/j.jbspin.2014.03.019. Epub 2014 Jun 20.

PMID:
24956990
9.

Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study.

Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E.

Rheumatology (Oxford). 2014 Nov;53(11):2035-43. doi: 10.1093/rheumatology/keu236. Epub 2014 Jun 10.

PMID:
24917564
10.

Effects of laser treatment on the expression of cytosolic proteins in the synovium of patients with osteoarthritis.

Barabás K, Bakos J, Zeitler Z, Bálint G, Nagy E, Lakatos T, Kékesi AK, Gáspár L, Szekanecz Z.

Lasers Surg Med. 2014 Oct;46(8):644-9. doi: 10.1002/lsm.22268. Epub 2014 Jun 7.

PMID:
24909318
11.

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.

Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M.

Rheumatology (Oxford). 2014 Dec;53(12):2143-54. doi: 10.1093/rheumatology/keu224. Epub 2014 Jun 6. Review.

12.

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis.

Gulyas K, Bodnar N, Nagy Z, Szamosi S, Horvath A, Vancsa A, Vegh E, Szabo Z, Szucs G, Szekanecz Z, Szanto S.

Eur J Health Econ. 2014 May;15 Suppl 1:S93-100. doi: 10.1007/s10198-014-0598-0. Epub 2014 May 16.

PMID:
24832840
13.

Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective.

Péntek M, Rojkovich B, Czirják L, Géher P, Keszthelyi P, Kovács A, Kovács L, Szabó Z, Szekanecz Z, Tamási L, Tóth ÁE, Ujfalussy I, Hevér NV, Strbák B, Baji P, Brodszky V, Gulácsi L.

Eur J Health Econ. 2014 May;15 Suppl 1:S73-82. doi: 10.1007/s10198-014-0596-2. Epub 2014 May 16.

PMID:
24832838
14.

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.

Baji P, Péntek M, Czirják L, Szekanecz Z, Nagy G, Gulácsi L, Brodszky V.

Eur J Health Econ. 2014 May;15 Suppl 1:S53-64. doi: 10.1007/s10198-014-0594-4. Epub 2014 May 16. Review.

15.

Biologics, cardiovascular effects and cancer.

Damjanov N, Nurmohamed MT, Szekanecz Z.

BMC Med. 2014 Mar 18;12:48. doi: 10.1186/1741-7015-12-48. Review.

16.

Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.

Futó G, Somogyi A, Szekanecz Z.

Clin Rheumatol. 2014 May;33(5):623-9. doi: 10.1007/s10067-014-2559-5. Epub 2014 Mar 6.

PMID:
24599677
17.

Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseases.

Kádár G, Balázs E, Soós B, Laduver A, Keszthelyi P, Szekanecz Z, Kovács L.

Clin Rheumatol. 2014 Mar;33(3):329-33. doi: 10.1007/s10067-014-2508-3. Epub 2014 Feb 5.

PMID:
24497172
18.

Follicular helper T cells in autoimmune diseases.

Papp G, Szabó K, Szekanecz Z, Zeher M.

Rheumatology (Oxford). 2014 Jul;53(7):1159-60. doi: 10.1093/rheumatology/ket434. Epub 2014 Jan 8. No abstract available.

PMID:
24402581
19.

Of mice and men: how animal models advance our understanding of T-cell function in RA.

Kobezda T, Ghassemi-Nejad S, Mikecz K, Glant TT, Szekanecz Z.

Nat Rev Rheumatol. 2014 Mar;10(3):160-70. doi: 10.1038/nrrheum.2013.205. Epub 2014 Jan 7. Review.

20.

[Systemic sclerosis and pregnancy. A review of the current literature].

Németh A, Szamosi S, Horváth A, Schönherr J, Nicksch E, Szekanecz Z, Szűcs G.

Z Rheumatol. 2014 Mar;73(2):175-9. doi: 10.1007/s00393-013-1267-x. Review. German.

PMID:
24306839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk